PCSK9 pathway and effect of PCSK9 antibody on LDL-R

Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews Drug Discovery. Mullard A. Cholesterol-lowering blockbuster candidates speed into Phase III trials. Nat Rev Drug Discov 2012; 11:817. Copyright © 2012. www.nature.com/nrd.